454 of 500
Biogen Idec
Financials: Latest Results
Rank: 454
Previous rank: 476
CEO: George A. Scangos
Headquarters:
133 Boston Post Rd.
Weston, MA. 02493
781-464-2000
Website: www.biogenidec.com
Network with Biogen Idec
Key financials
$ millions
% change from 2011
Revenues
5,516.5
9.3
Profits
1,380
11.8
Assets
10,130.1
Stockholder's equity
6,961.5
Market cap (on 3/29/2013)
45,518
Profits as % of
Revenues
25
Assets
13.6
Stockholders' equity
19.8
Earnings per share
2012$
5.76
% change from 2011
14.3
2002-2012 annual growth rate %
21.1
Total return to investors
%
2012
33
2002-2012 annual rate
16
From the May 20, 2013 issue


What do you think of Biogen Idec?
Companies are ranked by total revenues for their respective fiscal years. Included in the survey are companies that are incorporated in the U.S. and operate in the U.S. and file financial statements with a government agency. More
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.